Keeping Nanomedicine on Target.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33337166.
- Also identified by DOI 10.1021/acs.nanolett.0c04638 and PMC identifier 8005263.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A principal purpose of targeting or triggering is to improve the active agents’ therapeutic indices by preferentially increasing their concentrations at the desired site of effect.
Medical subject headings
- Nanomedicine